Compare COHN & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COHN | POCI |
|---|---|---|
| Founded | 1999 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3M | 32.6M |
| IPO Year | N/A | N/A |
| Metric | COHN | POCI |
|---|---|---|
| Price | $22.39 | $4.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 80.0K | 9.8K |
| Earning Date | 11-04-2025 | 02-12-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 6.29 | N/A |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $185,475,000.00 | $21,575,039.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.06 | ★ N/A |
| Revenue Growth | ★ 107.11 | 13.67 |
| 52 Week Low | $6.10 | $3.77 |
| 52 Week High | $32.60 | $5.34 |
| Indicator | COHN | POCI |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 59.63 |
| Support Level | $17.37 | $4.09 |
| Resistance Level | $32.60 | $4.43 |
| Average True Range (ATR) | 2.89 | 0.10 |
| MACD | -0.45 | 0.03 |
| Stochastic Oscillator | 32.67 | 91.89 |
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.